Featured Research

from universities, journals, and other organizations

Scientists identify molecular predictor of prognosis for pancreatic cancer patients

Date:
July 18, 2010
Source:
University of North Carolina School of Medicine
Summary:
Pancreatic cancer is one of the most challenging tumors to treat. Identifying patients who have more aggressive disease could better inform treatment decisions and predict survival prognosis. A new finding may help.

Pancreatic cancer is one of the most challenging tumors to treat. Identifying patients who have more aggressive disease could better inform treatment decisions and predict survival prognosis. A new finding from scientists at UNC Lineberger Comprehensive Cancer Center may help.

Related Articles


The team analyzed gene profiles of pancreatic tumors from patients with both localized and metastasized disease. They identified a six-gene "signature" associated with metastatic disease. Their study is the first to demonstrate that molecular differences in metastatic pancreatic cancer can be identified at earlier stages and that these differences are predictive of future disease behavior. This finding, if verified in further clinical studies, could help patients and physicians make more informed decisions about treatment and could offer new research opportunities into potential therapeutic targets to treat the disease.

Their findings were reported in the July 2010 issue of PLoS Medicine, published by the Public Library of Science.

"In our study we showed our six-gene signature to be superior to current methods used to stage disease and estimate prognosis," says study senior author, Jen Jen Yeh, MD, assistant professor of surgery and pharmacology at the UNC School of Medicine. "If we can better stage patients' disease, we can better determine those who may benefit most from chemotherapy before surgery or from surgery alone. As more therapies become available, this signature may be used to tailor treatment options."

Pancreatic cancer is often not diagnosed until it is advanced because the most common tumor type -- called pancreatic ductal adenocarcimona, that comprises over 90 percent of all pancreatic cancer -- rarely causes early noticeable symptoms. Survival rates for cancer that has spread are poor, on average only five to eight months. At present, treatment decisions and clinical prognosis are based on tumor size and lymph node status.

Study scientists compared and evaluated 30 tumor samples from patients with early and late-stage disease and identified the six-gene signature associated with late-stage disease. They then tested the prognostic value of this signature on a group of 67 patients with localized pancreatic cancer and confirmed the validity of the signature to identify patients with high-risk, aggressive disease.

At present, the only possibility of cure for pancreatic cancer is surgery which involves removal of the tumor, usually the head of the pancreas, part of the small intestine, a portion of the stomach, and other nearby tissues, a method called a Whipple procedure.

Says Yeh, "If patients have high risk, aggressive disease, this signature may be helpful for consideration of chemotherapy before surgery or, if patients are at increased risk for complications from the surgery, this information may help them decide whether or not to have the surgery."

Other UNC scientists are: Channing Der, PhD, and Jeran Stratford, PhD, from the department of pharmacology; Leigh Thorne, MD, from the department of pathology and laboratory medicine; Benjamin Calvo, MD; Hong Jin Kim, MD; and Jonathan Samuel, MD, from the department of surgery; Chuck Perou, PhD, from the department of genetics; J.S. Marron, PhD, department of biostatistics; Keith Volmar, MD, clinical pathologist at Rex Hospital, and Laura Caskey, research specialist, and Cheng Fan, research associate.

Other research team scientists are from UNC, Northwestern University, Chicago, IL; Eppley Cancer Institute, Omaha, NE; Northshore University HealthSystem, Baltimore MD; and Johns Hopkins Medical Institutions, Baltimore, MD.


Story Source:

The above story is based on materials provided by University of North Carolina School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jeran K Stratford, David J Bentrem, Judy M Anderson, Cheng Fan, Keith A Volmar, J S Marron, Elizabeth D Routh, Laura S Caskey, Jonathan C Samuel, Channing J Der, Leigh B Thorne, Benjamin F Calvo, Hong Jin Kim, Mark S Talamonti, Christine A Iacobuzio-Donahue, Michael A Hollingsworth, Charles M Perou, Jen Jen Yeh. A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma. PLoS Medicine, 2010; DOI: 10.1371/journal.pmed.1000307

Cite This Page:

University of North Carolina School of Medicine. "Scientists identify molecular predictor of prognosis for pancreatic cancer patients." ScienceDaily. ScienceDaily, 18 July 2010. <www.sciencedaily.com/releases/2010/07/100713171601.htm>.
University of North Carolina School of Medicine. (2010, July 18). Scientists identify molecular predictor of prognosis for pancreatic cancer patients. ScienceDaily. Retrieved November 23, 2014 from www.sciencedaily.com/releases/2010/07/100713171601.htm
University of North Carolina School of Medicine. "Scientists identify molecular predictor of prognosis for pancreatic cancer patients." ScienceDaily. www.sciencedaily.com/releases/2010/07/100713171601.htm (accessed November 23, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, November 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com
Raw: Paralyzed Marine Walks With Robotic Braces

Raw: Paralyzed Marine Walks With Robotic Braces

AP (Nov. 21, 2014) Marine Corps officials say a special operations officer left paralyzed by a sniper's bullet in Afghanistan walked using robotic leg braces in a ceremony to award him a Bronze Star. (Nov. 21) Video provided by AP
Powered by NewsLook.com
Milestone Birthdays Can Bring Existential Crisis, Study Says

Milestone Birthdays Can Bring Existential Crisis, Study Says

Newsy (Nov. 21, 2014) Researchers find that as people approach new decades in their lives they make bigger life decisions. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins